See more : Fidelity China Special Situations PLC (FCSS.L) Income Statement Analysis – Financial Results
Complete financial analysis of Kenvue Inc. (KVUE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kenvue Inc., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Gujarat Apollo Industries Limited (GUJAPOLLO.NS) Income Statement Analysis – Financial Results
- Beijing Energy International Holding Co., Ltd. (0686.HK) Income Statement Analysis – Financial Results
- HEICO Corporation (HEI-A) Income Statement Analysis – Financial Results
- Global Investments Limited (B73.SI) Income Statement Analysis – Financial Results
- Chemcon Speciality Chemicals Limited (CHEMCON.BO) Income Statement Analysis – Financial Results
Kenvue Inc. (KVUE)
About Kenvue Inc.
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 15.44B | 14.95B | 15.05B | 14.47B | 14.32B |
| Cost of Revenue | 6.80B | 6.67B | 6.64B | 6.62B | 6.66B |
| Gross Profit | 8.64B | 8.29B | 8.42B | 7.85B | 7.66B |
| Gross Profit Ratio | 55.96% | 55.42% | 55.93% | 54.25% | 53.49% |
| Research & Development | 399.00M | 375.00M | 355.00M | 320.00M | 391.00M |
| General & Administrative | 4.33B | 4.28B | 4.02B | 3.73B | 3.94B |
| Selling & Marketing | 1.35B | 1.36B | 1.46B | 1.23B | 1.26B |
| SG&A | 5.68B | 5.63B | 5.48B | 4.96B | 5.20B |
| Other Expenses | 50.00M | 4.00M | 25.00M | 3.00M | 59.00M |
| Operating Expenses | 6.13B | 5.62B | 5.41B | 4.86B | 5.26B |
| Cost & Expenses | 12.93B | 12.28B | 12.04B | 11.48B | 11.93B |
| Interest Income | 108.00M | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 358.00M | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 627.00M | 644.00M | 731.00M | 746.00M | 709.00M |
| EBITDA | 3.18B | 3.64B | 3.87B | 3.79B | 3.28B |
| EBITDA Ratio | 20.56% | 22.39% | 25.61% | 53.51% | 25.98% |
| Operating Income | 2.51B | 2.68B | 2.92B | -979.00M | 1.85B |
| Operating Income Ratio | 16.27% | 17.89% | 19.40% | -6.77% | 12.89% |
| Total Other Income/Expenses | -322.00M | -38.00M | 5.00M | -37.00M | 274.00M |
| Income Before Tax | 2.19B | 2.64B | 2.93B | -1.02B | 2.12B |
| Income Before Tax Ratio | 14.18% | 17.64% | 19.43% | -7.02% | 14.80% |
| Income Tax Expense | 526.00M | 550.00M | 894.00M | -137.00M | 685.00M |
| Net Income | 1.66B | 2.06B | 2.08B | -879.00M | 1.44B |
| Net Income Ratio | 10.77% | 13.81% | 13.80% | -6.08% | 10.02% |
| EPS | 0.90 | 1.08 | 1.08 | -0.47 | 0.76 |
| EPS Diluted | 0.87 | 1.08 | 1.08 | -0.47 | 0.76 |
| Weighted Avg Shares Out | 1.85B | 1.91B | 1.89B | 1.89B | 1.89B |
| Weighted Avg Shares Out (Dil) | 1.92B | 1.91B | 1.89B | 1.89B | 1.89B |
Kenvue (KVUE) Q2 Earnings and Revenues Beat Estimates
Kenvue stock up 9% after earnings beat; consumer health stars
Kenvue's stock jumps as Band-Aid, Tylenol parent beat profit and sales expectations
Listerine maker Kenvue beats estimates on strong essential health product sales
Kenvue Reports Second Quarter 2024 Results
All It Takes Is $10,000 Invested in Coca-Cola and Each of These 2 Dividend Kings to Generate Over $1,000 in Passive Income per Year
Is Kenvue The Next Big Dividend (Growth) Stock?
Kenvue Announces Board Changes with Two New Independent Directors
Analysts Estimate Kenvue (KVUE) to Report a Decline in Earnings: What to Look Out for
4 Top Dividend Stocks Yielding Over 4% to Buy Hand Over Fist Right Now for Decades of Passive Income
Source: https://incomestatements.info
Category: Stock Reports